ACT-AKI: A Randomized, Multicenter, Double-Blind,
Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney
Injury in Cardiac Surgery Subjects
PI: Francis Ferdinand, MD
CRC: Susan Herring, RN - 484.476.8514
To evaluate an investigational agent administered to patients post
on-pump cardiac surgery who develop AKI. On-Pump cardiac surgery
patients who have an elevation in Creatinine post-up of >0.5mg/dL
from pre-op baseline Creatinine within the first 48 hours after surgery.
For additional information on cardiovascular clinical
trials, please call Ann Marie Chikowski, BSN, RN, CCRC, Clinical
Research Manager at 484.476.3030.
For more information, call 1.866.CALL.MLH.